http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20080429-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4ffd97b6b0d1886d7e542c83683c3b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb5675788b6b811130cbd3e327a36907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e042be4cf2aee5cab35cedef792c5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde783c526fac3f40becce44452acac8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c616320db2c9d12f9af9947557c1e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abd2ff28f9d5280750e89ab0e196ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f58d54a70feaef466dcad88b66781474
publicationDate 2008-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20080429-T3
titleOfInvention DISUPSTITUTED PYRAZOLOBENZODIAZEPINES USEFUL AS INHIBITORS FOR CDK2 AND ANGIOGENESIS AND FOR TREATMENT OF Breast, colon, lung and prostate cancer
abstract Compound of formula IV, wherein R 1 is alkyl, alkoxy, halogen, COOH, COOalkyl, CN, C (O) N (R 6) 2, or (OCH 2 CH 2) n OCH 3, R 2 alkyl, halogen, alkyl substituted by halogen, OH, alkoxy, alkoxy substituted by halogen, phenyl, N (R6) 2, (OCH2CH2) nOCH3, O (CH2) mNR7R8, or is a 6-membered heterocycle optionally substituted by alkyl or C (O) OR6, or R1 and R2 together form a heterocyclic ring with 5 members; R3 is hydrogen or alkyl; R 4 is hydrogen, halogen, CN, NO 2, alkyl, or alkoxy; each R 6 is independently hydrogen or alkyl; R7 and R8 are each independently hydrogen, alkyl or alkoxyalkyl, or R7 and R8 taken together with the nitrogen atom to which they are attached form a 6-membered heterocycle optionally substituted with alkyl; each n is independently 1, 2, or 3; im is 2, 3, or 4; or a pharmaceutically acceptable salt thereof. The patent contains another 64 patent claims.
priorityDate 2004-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68801840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410538663

Total number of triples: 30.